|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Net sales | |
| Costs and expenses: | |
| Cost of products sold | |
| Research and development expense | |
| Selling, general and administrative expense | |
| Operating loss | |
| Other non-operating income, net | |
| Interest and amortization of debt discount and expense | |
| Net foreign exchange (losses)/gains | |
| Debt issuance costs | |
| Loss on debt extinguishment | |
| Fair value movement of derivatives | |
| Loss before income taxes from continuing operations | |
| Income tax (expense)/benefit | |
| Loss after income tax | |
| Share information | |
| Basic loss per share (in Dollars per share) | |
| Diluted loss per share (in Dollars per share) | |
| Total (loss)/gain is attributable to: | |
| Non-controlling interests | |
| Stockholders of the Company |
Loading...
